Bharat Biotech enters gene & cell therapies segment, launches India’ s only vertically integrated viral production facility
Bharat Biotech International Limited has launched India’ s only vertically integrated, purpose-designed Cell and Gene Therapy( CGT) Infrastructure & Viral Vector Production Facility at Genome Valley – expanding its expertise from vaccine innovation to leadingedge regenerative and personalized therapies. This 50,000-square-foot dedicated state-of-the-art facility ushers in a new era of gene and cell therapies to tackle scientific challenges.
Strides Pharma recognized in S & P Global Sustainability Yearbook 2025
Strides Pharma Science Limited has been recognized in the S & P Global Sustainability Yearbook 2025, placing it among the top 10 percent of companies globally. The S & P Global Sustainability Yearbook assesses companies across various industries based on ESG performance. For the 2025 edition, 7,690 companies across more than 60 industries were evaluated, with 780 making it into the Yearbook. Strides demonstrated strong performance across ESG dimensions.
BioTech
BD India provides knowledgesharing platform for lab personnel
To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment of Minimal Residual Disease( MRD) in Acute Leukemia & Myeloma, BD Life Sciences-Biosciences organized a 2- day workshop at the Christian Medical College( CMC) Vellore. This knowledge-sharing workshop was attended by nearly 75 participants, from across the country, Philippines, and Australia.
BIOVOICENEWS. COM 09